| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/01.CCM.0000157969.46388.A2 |
| P8608 | Fatcat ID | release_3qi7eufvi5coxct4ominqcpfwe |
| P698 | PubMed publication ID | 15818093 |
| P50 | author | Steffen Weber-Carstens | Q52881487 |
| P2093 | author name string | Steffen Wolf | |
| Konrad J Falke | |||
| Sven Bercker | |||
| Udo Kaisers | |||
| Maria Deja | |||
| Thilo Busch | |||
| Claudia Grimm | |||
| Friedrich Behse | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | acute respiratory distress syndrome | Q344873 |
| critical illness polyneuropathy | Q1140516 | ||
| P304 | page(s) | 711-715 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | Critical Care Medicine | Q5186605 |
| P1476 | title | Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome | |
| P478 | volume | 33 |
| Q37403257 | Are intensive care factors associated with depressive symptoms 6 months after acute lung injury? |
| Q38280677 | Assessment of intensive care unit-acquired weakness in young and old mice: An E. coli septic peritonitis model |
| Q79691466 | Building consensus on ICU-acquired weakness |
| Q24649694 | Clinical review: Critical illness polyneuropathy and myopathy |
| Q26799076 | Clinical review: intensive care unit acquired weakness |
| Q50218185 | Critical illness myopathy and polyneuropathy |
| Q40806336 | Critical illness polyneuropathy and myopathy as neurological complications of sepsis |
| Q37541645 | Critical illness polyneuropathy and myopathy in the intensive care unit |
| Q34218481 | Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. |
| Q34096385 | Critical illness polyneuropathy and myopathy: a systematic review |
| Q49885239 | Developing and evaluating an instrument to measure Recovery After INtensive care: the RAIN instrument |
| Q41789482 | Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial |
| Q40654966 | Effects of acute administration of corticosteroids during mechanical ventilation on rat diaphragm |
| Q28299355 | Elderly persons with ICU-acquired weakness: the potential role for β-hydroxy-β-methylbutyrate (HMB) supplementation? |
| Q84785495 | High dose methylprednisolone counteracts the negative effects of rocuronium on diaphragm function |
| Q50862714 | ICU-Acquired Weakness. |
| Q34586285 | Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit |
| Q33817911 | Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS. |
| Q34697264 | Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock |
| Q44967218 | Intensive care unit-acquired weakness in the critically ill : critical illness polyneuropathy and critical illness myopathy |
| Q38225008 | Intensive care unit-related generalized neuromuscular weakness due to critical illness polyneuropathy/myopathy in critically ill patients. |
| Q92128411 | Longtime Neurologic Outcome of Extracorporeal Membrane Oxygenation and Non Extracorporeal Membrane Oxygenation Acute Respiratory Distress Syndrome Survivors |
| Q33942530 | Maximum inspiratory pressure, a surrogate parameter for the assessment of ICU-acquired weakness. |
| Q46845084 | Neuromuscular abnormalities in critical illness |
| Q48058063 | Neuromuscular and neuropsychological assessments in survivors of acute respiratory distress syndrome: exploratory comparisons with an at-risk cohort. |
| Q33291172 | Neuromuscular dysfunction acquired in critical illness: a systematic review |
| Q80153785 | Neuromuscular function in survivors of the acute respiratory distress syndrome |
| Q37646839 | Physical complications in acute lung injury survivors: a two-year longitudinal prospective study |
| Q24201361 | Physical rehabilitation for critical illness myopathy and neuropathy |
| Q24187403 | Physical rehabilitation for critical illness myopathy and neuropathy. |
| Q36359477 | Polyneuropathy and myopathy in the elderly. |
| Q55127893 | Progressive mobility program and technology to increase the level of physical activity and its benefits in respiratory, muscular system, and functionality of ICU patients: study protocol for a randomized controlled trial. |
| Q36411244 | Reducing iatrogenic risks: ICU-acquired delirium and weakness--crossing the quality chasm |
| Q34587145 | Reversible tetraplegia after percutaneous nephrostolithotomy and septic shock: a case of critical illness polyneuropathy and myopathy with acute onset and complete recovery |
| Q37514662 | Review of Critical Illness Myopathy and Neuropathy |
| Q34027050 | Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study |
| Q38780204 | Tetraparetic critically ill patients show electrophysiological signs of myopathy |
| Q34483183 | The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill. |
| Q62072705 | The incidence of intensive care unit-acquired weakness syndromes: A systematic review |
| Q47743973 | Ventilatory strategies in patients with sepsis and respiratory failure |
| Q47317162 | Weakness acquired in the intensive care unit. Incidence, risk factors and their association with inspiratory weakness. Observational cohort study. |
| Q79429348 | [Critical illness myopathy in intensive care patients. Pathogenetic concepts and clinical management] |
| Q87164845 | [Intensive care unit acquired weakness. Pathogenesis, treatment, rehabilitation and outcome] |
| Q83022125 | [Medically induced myopathia] |
Search more.